BioBridgeXAll companies

Adaptimmune Therapeutics PLC

Biotechnology company · Abingdon, England, United Kingdom

Adaptimmune Therapeutics PLC is a biotechnology company headquartered in Abingdon, England, United Kingdom. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $104 million sold in a notice filed in 2014. It is registered with UK Companies House under company number 09338148.

Profile compiled from public records. Is this your company? Request a correction or update

Adaptimmune Therapeutics at a glance

Typebiotechnology company
HeadquartersAbingdon, England, United Kingdom
Earliest incorporation on record2014
SEC industryBiological Products, (No Diagnostic Substances)
Registered activities (UK)Research and experimental development on biotechnology
UK company number09338148
SEC CIK1621227

What does Adaptimmune Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $103.8 million sold (2014).

Frequently asked questions about Adaptimmune Therapeutics

Where is Adaptimmune Therapeutics headquartered?

Adaptimmune Therapeutics PLC is headquartered in Abingdon, England, United Kingdom.

What does Adaptimmune Therapeutics do?

Adaptimmune Therapeutics PLC is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

When was Adaptimmune Therapeutics founded?

The earliest incorporation on record for Adaptimmune Therapeutics PLC is in 2014, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Contains public sector information licensed under the Open Government Licence v3.0 (UK Companies House).

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.